Sign in Subscribe
Cancer

Groundbreaking Study Screens 100,000 Newborn Babies in England for Rare Genetic Conditions

Strategic Insights

— 2 min read

Researchers at Genomics England, in partnership with NHS England, are conducting a revolutionary study that screens 100,000 newborn babies for dozens of genetic conditions. The Generation Study, launched in 2024, uses whole genome sequencing to detect over 200 rare conditions, some of which can cause a progressive loss of physical and mental skills. One family's experience highlights the potential of this screening: 6-month-old Freddie Underhay was diagnosed with hereditary retinoblastoma, a rare and aggressive form of eye cancer, just four weeks after birth due to the study's early detection. This condition, which affects only around 44 children per year in the UK, often goes undetected until later in life when the disease has progressed.

Key Takeaways:

  • The Generation Study, a research project in partnership with NHS England, screens 100,000 newborn babies for dozens of genetic conditions, including over 200 rare conditions.
  • The study uses whole genome sequencing, which provides a readout of a person's entire genetic code, to identify changes related to specific health conditions.
  • The Generation Study is currently available at 51 hospitals in England and has already generated over 60 'condition suspected' results for the NHS, with more than 20,000 families participating.
  • One family's experience, Freddie Underhay's diagnosis with hereditary retinoblastoma, showcases the life-changing impact of the study's early detection and treatment.
  • The study's findings will inform the UK Government's long-term ambition to offer genomic sequencing to all newborns as part of routine care.
  • Dr. Rich Scott, Genomics England's CEO, emphasizes the potential of genomics to transform healthcare and prevent sickness, not just treat it, citing the study's example.
  • Professor Dame Sue Hill, chief scientific officer for England, highlights the study as a major step forward for the NHS in the use of whole genome sequencing in newborns.

Statistics:

  • Over 20,000 families have joined the Generation Study, with more than 60 'condition suspected' results returned by Genomics England to the NHS for confirmatory testing.
  • The study aims to identify over 200 rare conditions, some of which can cause a progressive loss of physical and mental skills.
  • Hereditary retinoblastoma, diagnosed in Freddie Underhay, affects only around 44 children per year in the UK and is often undetected until later in life.
  • The average time for rare condition diagnosis in the UK is around five years, by which point treatment, if it exists, may be less effective.

Sources:

  • [Source 1: The study was launched in 2024](https://t.co/rLJv2SJ6ya)
  • [Source 2: Over 20,000 families have joined the study](https://t.co/rLJv2SJ6ya)
  • [Source 3: The study uses whole genome sequencing](https://t.co/rLJv2SJ6ya)
  • [Source 4: Freddie Underhay's diagnosis with hereditary retinoblastoma](https://t.co/rMciEjxnle)
  • [Source 5: Genomics England's partnership with NHS England](https://t.co/rLJv2SJ6ya)

Read more